Clinical trial Recruiting at 1 site Interventional Ages 6 to 18

Assessing health and exercise responses in children with chronic diseases

Official title: Evaluation of Chronic Pathologies Impact and Their Treatments on Children and Teen Physical Fitness.

Run by University Hospital, Clermont-Ferrand · NCT03913962 · Data updated 2026-11-12

This study is testing how chronic diseases and their treatments affect physical fitness in children and teens to find ways to improve their health and quality of life through exercise.

More Diabetes trials

Quick facts

Study typeInterventional
Ages6 Years to 18 Years
SexAll
Enrollment300 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedMay 2, 2019
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedNovember 9, 2026
Trial IDNCT03913962 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 18 with chronic pathologies that affect muscle mass and function.

Probably not a fit

Patients currently on systemic corticosteroids or with contraindications to physical activity may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effects of chronic pediatric diseases and their treatments on physical fitness in children and adolescents. Participants will be grouped based on disease activity and treatment status to assess how these factors influence physical fitness. The study will involve physical tests to measure body composition, muscle strength, and metabolic flexibility, alongside blood tests to evaluate inflammatory states. The goal is to improve treatment strategies through physical activity, reducing pain and enhancing quality of life.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment approaches that enhance physical fitness and quality of life for children with chronic diseases.

How similar studies have gone: Other studies have shown promise in using physical activity as a therapeutic approach for chronic pediatric conditions, indicating potential success for this innovative methodology.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* for patients:
* Aged between 6 and 18-year-old
* Male or female
* Presenting a chronic pathology / having a treatment which is known to alter muscle mass and function, metabolism and body composition
* Included in the active list of the hospital centre of Clermont-Ferrand
* Free and informed consent of the holders of parental authority and the patient
* Affiliated with the social security system for control:
* Aged between 6 and 18-year-old
* Male or female
* Free and informed consent of the holders of parental authority and the patient
* Affiliated with the social security system

Exclusion Criteria:

* for patients:
* Treatment by systemic corticoids (\>1 week in the 30 days before test)
* Contraindication to sport practice
* Active infection for control:
* Contraindication to sport practice
* Chronic pathology susceptible to alter muscle mass and function, metabolism and body composition
* Treatment susceptible to alter metabolism
* Active infection

Where it's running

  • Chu Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.